INFINIDOSE

Serial Number 98365341
730

Registration Progress

Application Filed
Jan 19, 2024
Under Examination
Nov 19, 2024
Approved for Publication
Sep 24, 2024
Published for Opposition
Sep 24, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Nov 19, 2025 120 days

Trademark Image

INFINIDOSE

Basic Information

Serial Number
98365341
Filing Date
January 19, 2024
Published for Opposition
September 24, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
May 9, 2025
Application
Pending
Classes
005 040 042

Rights Holder

Aprecia Pharmaceuticals, LLC

16
Address
7200 Industrial Row Drive, Suite 200
Mason, OH 45040

Ownership History

Aprecia Pharmaceuticals, LLC

Original Applicant
16
Blue Ash, OH

Aprecia Pharmaceuticals, LLC

Owner at Publication
16
Mason, OH

Legal Representation

Attorney
Brian O'Donnell

USPTO Deadlines

Next Deadline
120 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 19, 2025
Extension Available
Until November 19, 2025

Application History

22 events
Date Code Type Description Documents
May 9, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 9, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 9, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
May 8, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 12, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 12, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 12, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Mar 12, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 12, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 12, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 19, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 24, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 24, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 16, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 16, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 16, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 16, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 16, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 15, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 25, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 19, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, a drug delivery system consisting of a multilayered tablet which can be tailored to individual patient needs by providing various functionalities, precision dosing of one or more APIs, and/or enhanced bioavailability for poorly soluble compounds through flexible compositions, unique designs, and different routes of oral administration routes
Class 040
pharmaceutical manufacturing services to the order and/or specification of others
Class 042
Development of pharmaceutical and nutraceutical preparations for others, namely, pharmaceutical and nutraceutical compounds in a multilayered tablet form for the rapid dispersion of a wide variety of therapeutic agents; research and development in the pharmaceutical and nutraceutical fields for others, namely, research and development of pharmaceutical and nutraceutical compounds in a multilayered tablet form for the rapid dispersion of a wide variety of therapeutic agents

Additional Information

Pseudo Mark
INFINITE DOSE

Classification

International Classes
005 040 042